company background image
4218 logo

Nichiban TSE:4218 Stock Report

Last Price

JP¥1.95k

Market Cap

JP¥39.7b

7D

1.2%

1Y

2.1%

Updated

28 Mar, 2024

Data

Company Financials +

4218 Stock Overview

Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Asia and Europe.

4218 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Nichiban Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nichiban
Historical stock prices
Current Share PriceJP¥1,952.00
52 Week HighJP¥2,128.00
52 Week LowJP¥1,680.00
Beta0.31
1 Month Change4.00%
3 Month Change12.64%
1 Year Change2.09%
3 Year Change0.88%
5 Year Change-13.05%
Change since IPO43.53%

Recent News & Updates

Recent updates

Shareholder Returns

4218JP Commercial ServicesJP Market
7D1.2%0.9%1.7%
1Y2.1%22.9%37.6%

Return vs Industry: 4218 underperformed the JP Commercial Services industry which returned 22.9% over the past year.

Return vs Market: 4218 underperformed the JP Market which returned 37.6% over the past year.

Price Volatility

Is 4218's price volatile compared to industry and market?
4218 volatility
4218 Average Weekly Movement2.1%
Commercial Services Industry Average Movement3.5%
Market Average Movement3.9%
10% most volatile stocks in JP Market8.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4218 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4218's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19181,268Toshiaki Takatsuhttps://www.nichiban.co.jp

Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, and hemostatic and first-aid bandages; and sports tapes, underwraps, scissors, and bags. The company also provides curative drug for corns, calluses, and warts; Navel Compression pack, which is used for umbilical hernia compression treatment in infants; and fabric plasters, permeable film and puncture site protection dressings, absorbent hemostatic pressure dressings, and non-woven surgical tapes.

Nichiban Co., Ltd. Fundamentals Summary

How do Nichiban's earnings and revenue compare to its market cap?
4218 fundamental statistics
Market capJP¥39.73b
Earnings (TTM)JP¥2.69b
Revenue (TTM)JP¥46.98b

14.8x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4218 income statement (TTM)
RevenueJP¥46.98b
Cost of RevenueJP¥33.35b
Gross ProfitJP¥13.63b
Other ExpensesJP¥10.94b
EarningsJP¥2.69b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 13, 2024

Earnings per share (EPS)131.93
Gross Margin29.01%
Net Profit Margin5.72%
Debt/Equity Ratio4.9%

How did 4218 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

27%

Payout Ratio

Does 4218 pay a reliable dividends?

See 4218 dividend history and benchmarks
When do you need to buy 4218 by to receive an upcoming dividend?
Nichiban dividend dates
Ex Dividend DateMar 28 2024
Dividend Pay DateJul 01 2024
Days until Ex dividend1 day
Days until Dividend pay date94 days

Does 4218 pay a reliable dividends?

See 4218 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.